Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
This first evidence of nirsevimab's effectiveness in China validates its value in a novel geographical and implementation ...
HIGHLIGHTS: 174,000 meters of exploration and grade control drilling conducted in 2025, with 36% directed towards the Koné ...
Background Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results